Similarly, the null effect remained consistent across studies using different diagnostic definitions of TB infection—namely, TST conversion over shorter follow-up periods and interferon-gamma release assay (IGRA), such as QuantiFERON-TB (QFT), conversion over longer durations. The gene discussed is IFNG; the disease is tuberculosis.